MarketCap
United Therapeutics Corporation UTHR
€ 531.75
0.97%
Facebook
X
Telegram
United Therapeutics Corporation EV | UTHR
EV Jährlich United Therapeutics Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22.8 B | 13.5 B | 10.1 B | 11.4 B | 7.78 B | 7.87 B | 4.61 B | 4.98 B | 6.04 B | 6.43 B | 5.42 B | 7.02 B | 5.82 B | 3.16 B | 3.24 B | 3.1 B | 2.42 B | 2.03 B | -139 M |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 22.8 B | -139 M | 6.72 B |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Vericel Corporation
VCEL
|
1.92 B | $ 42.99 | 1.08 % | $ 2.16 B |  USA |
 |
Veracyte
VCYT
|
2.78 B | $ 48.22 | 0.61 % | $ 3.79 B | USA |
 |
Champions Oncology
CSBR
|
102 M | $ 4.82 | 2.12 % | $ 66.7 M | USA |
 |
Mersana Therapeutics
MRSN
|
106 M | - | - | $ 3.56 B | USA |
 |
Vir Biotechnology
VIR
|
1.02 B | $ 11.02 | 4.27 % | $ 1.53 B | USA |
 |
Viking Therapeutics
VKTX
|
3.09 B | $ 24.23 | -0.72 % | $ 2.73 B | USA |
 |
CymaBay Therapeutics
CBAY
|
3.36 B | - | - | $ 3.45 B | USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
248 M | - | - | $ 384 M |  Britain |
 |
Cabaletta Bio
CABA
|
253 M | $ 1.34 | -9.18 % | $ 135 M | USA |
 |
CytomX Therapeutics
CTMX
|
971 M | $ 2.23 | -4.09 % | $ 308 M | USA |
 |
Vanda Pharmaceuticals
VNDA
|
435 M | $ 3.95 | -1.62 % | $ 233 M | USA |
 |
Allakos
ALLK
|
31 K | - | - | $ 28.6 M | USA |
 |
Timber Pharmaceuticals
TMBR
|
388 K | - | - | $ 717 K | USA |
 |
Verrica Pharmaceuticals
VRCA
|
58.9 M | $ 3.4 | -3.68 % | $ 36.2 M | USA |
 |
Viridian Therapeutics
VRDN
|
2.95 B | $ 23.31 | 4.2 % | $ 2.37 B | USA |
 |
G1 Therapeutics
GTHX
|
227 M | - | - | $ 370 M | USA |
 |
Verastem
VSTM
|
388 M | $ 9.9 | -1.34 % | $ 686 M | USA |
 |
VistaGen Therapeutics
VTGN
|
3.96 M | $ 0.17 | -3.9 % | $ 6.47 M | USA |
 |
Voyager Therapeutics
VYGR
|
232 M | $ 1.76 | 0.86 % | $ 103 M | USA |
|
Amryt Pharma plc
AMYT
|
2.89 B | - | - | $ 621 M | Britain |
 |
Kinnate Biopharma
KNTE
|
81.2 M | - | - | $ 123 M | USA |
|
Cerevel Therapeutics Holdings
CERE
|
6.84 B | - | - | $ 7.29 B | USA |
 |
NexImmune
NEXI
|
5.52 M | - | 70.13 % | $ 4.12 M | USA |
 |
Wave Life Sciences Ltd.
WVE
|
2.11 B | $ 3.23 | -0.16 % | $ 545 M |  Singapore |
 |
Theravance Biopharma
TBPH
|
574 M | $ 17.03 | 0.03 % | $ 857 M |  Cayman-islands |
 |
Xenetic Biosciences
XBIO
|
-2.54 M | $ 1.72 | 3.78 % | $ 2.93 M | USA |
|
XBiotech
XBIT
|
-45.4 M | $ 1.82 | -5.7 % | $ 55.5 M | USA |
 |
Xenon Pharmaceuticals
XENE
|
2.24 B | $ 35.76 | 1.19 % | $ 2.83 B |  Canada |
 |
Xeris Pharmaceuticals
XERS
|
1.23 B | $ 10.21 | 0.05 % | $ 1.64 B | USA |
 |
X4 Pharmaceuticals
XFOR
|
66 M | $ 3.26 | 0.46 % | $ 138 M | USA |
 |
IMV
IMV
|
23.6 M | - | - | $ 13.1 M | Canada |
 |
22nd Century Group
XXII
|
1.92 M | $ 0.09 | -54.43 % | $ 16.6 K | USA |
 |
Karuna Therapeutics
KRTX
|
11.7 B | - | - | $ 12.2 B | USA |
 |
Chimerix
CMRX
|
-6.72 M | - | - | $ 756 M | USA |
 |
Atreca
BCEL
|
94.8 M | - | -11.76 % | $ 5.79 M | USA |
 |
LogicBio Therapeutics
LOGC
|
53.4 M | - | - | $ 229 M | USA |
 |
Zai Lab Limited
ZLAB
|
21.4 B | $ 24.36 | 1.35 % | $ 26.7 B |  China |
|
89bio
ETNB
|
928 M | - | - | $ 1.55 B | USA |
 |
Zentalis Pharmaceuticals
ZNTL
|
229 M | $ 2.06 | -6.79 % | $ 148 M | USA |
 |
Zymeworks
ZYME
|
783 M | $ 28.38 | 0.57 % | $ 1.46 B | Canada |
 |
Fusion Pharmaceuticals
FUSN
|
1.39 B | - | - | $ 1.41 B | Canada |
 |
Gritstone Oncology
GRTS
|
339 M | - | 0.42 % | $ 213 M | USA |
 |
Harpoon Therapeutics
HARP
|
38.3 M | - | - | $ 763 M | USA |
 |
HOOKIPA Pharma
HOOK
|
-8.35 M | - | -6.92 % | $ 79.4 M | USA |
 |
Guardion Health Sciences
GHSI
|
-2.59 M | - | -0.31 % | $ 3.64 M | USA |
 |
Opiant Pharmaceuticals
OPNT
|
102 M | - | - | $ 109 M | USA |
 |
Akouos
AKUS
|
107 M | - | 0.23 % | $ 488 M | USA |
 |
Otonomy
OTIC
|
90.8 M | - | -1.96 % | $ 4.68 M | USA |
 |
Aridis Pharmaceuticals
ARDS
|
38.2 M | - | 17.91 % | $ 11.1 M | USA |